Efficacy and safety of the compound Chinese medicine SaiLuoTong in vascular dementia: A randomized clinical trial

INTRODUCTION: No licensed medications are available to treat vascular dementia (VaD). METHODS: Patients were randomly assigned to experimental groups (SaiLuoTong [SLT] 360 or 240 mg for groups A and B for 52 weeks, respectively) or placebo group (SLT 360 mg and 240 mg for group C only from weeks 27...

Descripción completa

Detalles Bibliográficos
Autores principales: Jia, Jianping, Wei, Cuibai, Chen, Shuoqi, Li, Fangyu, Tang, Yi, Qin, Wei, Shi, Lu, Gong, Min, Xu, Hui, Li, Fang, He, Jia, Song, Haiqing, Yang, Shanshan, Zhou, Aihong, Wang, Fen, Zuo, Xiumei, Chu, Changbiao, Liang, Junhua, Jia, Longfei, Gauthier, Serge
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Featured Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6021260/
https://www.ncbi.nlm.nih.gov/pubmed/29955654
http://dx.doi.org/10.1016/j.trci.2018.02.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6021260/
https://www.ncbi.nlm.nih.gov/pubmed/29955654
http://dx.doi.org/10.1016/j.trci.2018.02.004

Ejemplares similares